{"Tumor": [0], "necrosis": [1, 14], "factor": [2, 10], "alpha": [3], "(TNF-\u03b1)": [4], "was": [5], "initially": [6], "recognized": [7], "as": [8, 28, 84, 161], "a": [9, 29, 127], "that": [11], "causes": [12], "the": [13, 60, 78, 89, 99, 108, 147], "of": [15, 32, 65, 80, 88, 101, 110, 129, 149], "tumors,": [16], "but": [17], "it": [18], "has": [19, 93, 105], "been": [20, 94], "recently": [21], "identified": [22], "to": [23, 37, 49, 77], "have": [24, 122], "additional": [25], "important": [26], "functions": [27], "pathological": [30, 81], "component": [31], "autoimmune": [33, 85, 130, 153, 165], "diseases.": [34, 86, 166], "TNF-\u03b1": [35, 66, 90, 115, 120, 134, 150], "binds": [36], "two": [38], "different": [39], "receptors,": [40], "which": [41, 104, 158], "initiate": [42], "signal": [43], "transduction": [44], "pathways.": [45], "These": [46], "pathways": [47], "lead": [48, 76], "various": [50], "cellular": [51], "responses,": [52], "including": [53, 114], "cell": [54], "survival,": [55], "differentiation,": [56], "and": [57, 73, 96, 132, 155], "proliferation.": [58], "However,": [59], "inappropriate": [61], "or": [62], "excessive": [63], "activation": [64], "signaling": [67, 91, 135, 151], "is": [68], "associated": [69], "with": [70], "chronic": [71], "inflammation": [72], "can": [74], "eventually": [75], "development": [79, 109], "complications": [82], "such": [83], "Understanding": [87], "mechanism": [92], "expanded": [95], "applied": [97], "for": [98], "treatment": [100], "immune": [102], "diseases,": [103, 131], "resulted": [106], "in": [107, 126], "effective": [111], "therapeutic": [112, 162], "tools,": [113], "inhibitors.": [116], "Currently,": [117], "clinically": [118, 139], "approved": [119], "inhibitors": [121, 136], "shown": [123], "noticeable": [124], "potency": [125], "variety": [128], "novel": [133], "are": [137, 159], "being": [138], "evaluated.": [140], "In": [141], "this": [142], "review,": [143], "we": [144], "briefly": [145], "introduce": [146], "impact": [148], "on": [152], "diseases": [154], "its": [156], "inhibitors,": [157], "used": [160], "agents": [163], "against": [164]}